A newly characterized group of pharmacological compounds, when administered orally, blocks both the inflammation and nerve cell damage seen in mouse models of multiple sclerosis (MS), revealed a study published in the journal Nature Neuroscience. Lead author Jeffery Haines at the Icahn School of Medicine at Mount Sinai said, "The multiple sclerosis drugs currently on the market and being tested elsewhere seek to reduce the immune attack on cells, but none of them ...
You have just read an article categorized health
titled New Oral Therapy for Multiple Sclerosis.
Written by:
editor - Monday, March 2, 2015
There are currently no comments for "New Oral Therapy for Multiple Sclerosis"
Post a Comment